(19)
(11) EP 4 232 149 A2

(12)

(88) Date of publication A3:
30.06.2022

(43) Date of publication:
30.08.2023 Bulletin 2023/35

(21) Application number: 21882226.0

(22) Date of filing: 20.10.2021
(51) International Patent Classification (IPC): 
A61P 17/00(2006.01)
C07D 413/14(2006.01)
A61P 27/02(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 17/00; A61P 27/02; C07H 17/00
(86) International application number:
PCT/IB2021/000707
(87) International publication number:
WO 2022/084738 (28.04.2022 Gazette 2022/17)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 21.10.2020 US 202063094793 P
05.04.2021 US 202163170988 P

(71) Applicant: AZURA OPHTHALMICS LTD
6314305 Tel Aviv (IL)

(72) Inventors:
  • HOLMES, Ian
    Melbourne (AU)
  • ALSTER, Yair
    6314305 Tel Aviv (IL)
  • BARASH, Hila
    6314305 Tel Aviv (IL)
  • BOSWORTH, Charles
    6314305 Tel Aviv (IL)
  • RAFAELI, Omer
    6314305 Tel Aviv (IL)
  • BURK, Robert, M.
    6314305 Tel Aviv (IL)
  • GLEESON, Marc
    Melbourne (AU)
  • STEWART, Mark, Richard
    Walden, Essex CB10 1XL (GB)
  • DUNN, Jonathan
    Walden, Essex CB10 1XL (GB)
  • NICHOLLS, Alexander, James
    Walden, Essex CB10 1XL (GB)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS